Under the GST 2.0 reform effective 22 September 2025, most medicines and pharmaceutical products are now taxed at 5% (cut from 12%). A notified list of 36 life-saving, cancer and rare-disease drugs is Nil (fully exempt). Most medical devices are also 5% (cut from 12%/18%), and contraceptives remain Nil.
GST Rate on Medicines & Devices — Decision Table
Current GST rates by pharmaceutical category after the 22 September 2025 rationalisation, with typical HSN codes.
| Product / Category | GST Rate | HSN | Notes |
|---|---|---|---|
| General medicines & formulations | 5% | 3003 / 3004 | Most OTC & prescription drugs (was 12%) |
| Notified life-saving drugs (36 drugs) | Nil | 3004 | Cancer, rare-disease & severe chronic — exempt |
| Insulin & human vaccines | 5% | 3002 / 3004 | Concessional medicament rate |
| Branded Ayurvedic / Unani / Homeopathic | 5% | 3003 / 3004 | Branded = registered trademark |
| Unbranded Ayurvedic formulations | Nil | 3003 | No brand name / trademark — exempt |
| Medical devices & apparatus | 5% | 9018–9022 | Cut from 12%/18% on 22 Sep 2025 |
| Diagnostic / test kits | 5% | 3822 | Glucose, pregnancy & clinical kits |
| Coronary stents & implants | 5% | 9021 | Medical device category |
| Contraceptives / condoms | Nil | 4014 / 3006 | Notified contraceptives — exempt |
| Hand sanitiser / hand rub | 18% | 3808 / 3402 | Not a medicament — standard slab |
Rates reflect the GST 2.0 two-slab structure effective 22 September 2025. Confirm the exact HSN on the official GST portal before invoicing — 8-digit codes vary by drug.
Life-Saving Drugs Now at Nil GST
From 22 September 2025 the GST Council fully exempted 36 critical drugs — 33 moved from 12% to Nil and 3 cancer/rare-disease drugs from 5% to Nil. The aim is patient affordability for cancer, rare diseases and severe chronic conditions.
A Nil-rated (exempt) medicine blocks the seller's Input Tax Credit on inputs for that product, unlike a 5% taxable supply where ITC flows. Pharmacies stocking a mix of Nil and 5% items must apportion input credit carefully to stay compliant.
Selling a mix of exempt and 5% medicines? Get your ITC apportionment checked.
Talk to a GST Expert →Old GST vs New GST on Medicines
The GST 2.0 rationalisation abolished the 12% slab for most pharma and cut rates sharply. Here is the before-and-after for the common categories.
| Category | Old Rate (till 21 Sep 2025) | New Rate (from 22 Sep 2025) |
|---|---|---|
| General medicines | 12% | 5% |
| Life-saving / cancer / rare-disease drugs | 5% / 12% | Nil |
| Medical devices & apparatus | 12% / 18% | 5% |
| Diagnostic kits | 12% | 5% |
| Branded AYUSH medicines | 12% | 5% |
Sale price of a ₹100 medicine strip drops from ₹112 to ₹105; a ₹100 exempt life-saving drug drops to ₹100.
Old 12% medicine
New 5% medicine
Need to re-price stock and update your POS for the new 5% rate?
Get GST Advice →ITC Chain — Manufacturer to Pharmacy
A GST-registered pharmacy, distributor or manufacturer on the regular scheme can claim full Input Tax Credit on medicine purchases, provided the supplier filed GSTR-1 and the invoice appears in GSTR-2B.
Regular scheme suits you if
- You want full ITC on purchases & overheads
- Turnover is high with thin margins
- You supply to B2B / other registered dealers
Composition (1%) may suit if
- Turnover is up to ₹1.5cr & mostly retail
- You want simpler quarterly compliance
- You can absorb loss of ITC on purchases
A pharmacy under the composition scheme pays a flat 1% of turnover but cannot claim ITC and cannot charge GST on the bill — files quarterly CMP-08 and annual GSTR-4.
Not sure whether regular or composition is cheaper for your pharmacy?
Talk to a GST Expert →GST on Medicines in Hospitals
Healthcare services by a clinical establishment are exempt. Medicines supplied as part of an in-patient treatment package are a composite healthcare supply and are exempt; a standalone hospital pharmacy selling to out-patients charges normal GST (5% or Nil).
| Situation | GST on Medicine | Reason |
|---|---|---|
| In-patient treatment package | Exempt | Composite healthcare supply |
| Out-patient pharmacy sale | 5% | Standalone taxable supply |
| Life-saving drug (any setting) | Nil | Notified exempt drug |
Exempt supplies block ITC on related inputs under Section 17(2) of the CGST Act.
Pharma GST Compliance Checklist
Registration is mandatory once aggregate turnover crosses ₹40 lakh for a goods supplier (₹20 lakh in special-category states). Here is the compliance picture for a pharmacy, distributor or manufacturer:
- GST registration (GSTIN)
- Correct HSN & rate mapping
- Tax invoice / bill of supply
- ITC reconciliation (GSTR-2B)
- Nil vs 5% apportionment
- GSTR-1 (outward supplies)
- GSTR-3B (monthly/quarterly)
- E-invoicing applicability
- E-way bill on stock movement
- GSTR-9 annual return
- Drug licence & records
- Composition CMP-08 / GSTR-4 (if opted)
After the 22 September 2025 cut, the biggest compliance trap is mixing Nil-rated life-saving drugs with 5% stock — you must reverse ITC attributable to exempt sales. Map every SKU to the correct HSN and rate in your billing software before you invoice.
Frequently Asked Questions
Related TaxClue services
GST Compliance for Your Pharmacy or Pharma Business
From the new 5% medicine rate and Nil life-saving drugs to ITC reconciliation and annual returns — TaxClue's CA-led team handles GST for pharmacies, distributors and manufacturers, 100% online across India.